Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity
Faranak Vahid-Ansari, Min Zhang, Amin Zahrai, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Targeting PI3K-AKT/mTOR signaling in the prevention of autism
Aarti Sharma, Sidharth Mehan
Neurochemistry International (2021) Vol. 147, pp. 105067-105067
Closed Access | Times Cited: 87
Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders
Adrian Newman‐Tancredi, Ronan Depoortère, Mark S. Kleven, et al.
Pharmacology & Therapeutics (2021) Vol. 229, pp. 107937-107937
Closed Access | Times Cited: 55
Psychological mechanisms and functions of 5-HT and SSRIs in potential therapeutic change: Lessons from the serotonergic modulation of action selection, learning, affect, and social cognition
Clark Roberts, Barbara J. Sahakian, Trevor W. Robbins
Neuroscience & Biobehavioral Reviews (2020) Vol. 119, pp. 138-167
Closed Access | Times Cited: 54
Neuroimmunology of depression
Erika Sarno, Adam J. Moeser, Alfred J. Robison
Advances in pharmacology (2021), pp. 259-292
Open Access | Times Cited: 54
Rewiring of the Serotonin System in Major Depression
Faranak Vahid-Ansari, Paul R. Albert
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 51
A neurobiological perspective on social influence: Serotonin and social adaptation
Patricia Duerler, Franz X. Vollenweider, Katrin H. Preller
Journal of Neurochemistry (2022) Vol. 162, Iss. 1, pp. 60-79
Open Access | Times Cited: 30
Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression
Amin Zahrai, Faranak Vahid-Ansari, Mireille Daigle, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 34
Retinoic acid and depressive disorders: Evidence and possible neurobiological mechanisms
P. Hu, Anne‐Marie van Dam, Yu Wang, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 112, pp. 376-391
Open Access | Times Cited: 33
Serotonin modulation of hippocampal functions: From anatomy to neurotherapeutics
Cristiano Bombardi, Annamaria Grandis, Nela Pivac, et al.
Progress in brain research (2021), pp. 83-158
Closed Access | Times Cited: 32
Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants
Khushboo, Nikhat J. Siddiqi, Maria de Lourdes Pereira, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3564-3584
Closed Access | Times Cited: 22
Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain
Jurga Bernatonienė, Arūnas Ščiupokas, Dalia M. Kopustinskienė, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1799-1799
Open Access | Times Cited: 12
The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activation
Hugo R. Arias, Deborah Rudin, Dustin J. Hines, et al.
European Journal of Pharmacology (2024) Vol. 966, pp. 176329-176329
Open Access | Times Cited: 4
Rapid reorganization of serotonin projections and antidepressant response to 5-HT1A-biased agonist NLX-101 in fluoxetine-resistant cF1ko mice.
Faranak Vahid-Ansari, Adrian Newman‐Tancredi, Alberto Francisco Fuentes-Alvarenga, et al.
Neuropharmacology (2024) Vol. 261, pp. 110132-110132
Open Access | Times Cited: 4
Rescue of respiratory and cognitive impairments in Rett Syndrome mice using NLX-101, a selective 5-HT1A receptor biased agonist
Daniela Monteiro-Fernandes, Ian Charles, Sara Guerreiro, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 117989-117989
Closed Access
BIOCHEMISTRY AND PATHOCHEMISTRY OF SEROTONIN IN THE PATHOGENESIS OF MIGRAINE. ASPECTS OF DRUG THERAPY
S V Smirnov, М. А. Постников, O. Kuznetsova, et al.
Applied Information Aspects of Medicine (Prikladnye informacionnye aspekty mediciny) (2025) Vol. 28, Iss. 1, pp. 98-108
Closed Access
Enhanced systemic delivery of mirtazapine through transdermal drug-in-adhesive matrix: A sustained-release approach
R Satpute, Pramod S. Salve, Mohammad Qutub, et al.
Next Nanotechnology (2025) Vol. 8, pp. 100151-100151
Open Access
In vivo biased agonism at 5-HT1A receptors: characterisation by simultaneous PET/MR imaging
Benjamin Vidal, Sylvain Fieux, Jérôme Redouté, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 11, pp. 2310-2319
Open Access | Times Cited: 31
P2X7 receptor-mediated depression-like reactions arising in the mouse medial prefrontal cortex
Wenjing Ren, Yafei Zhao, Jie Li, et al.
Cerebral Cortex (2023) Vol. 33, Iss. 14, pp. 8858-8875
Closed Access | Times Cited: 9
Effects of prolonged escitalopram administration on long-term potentiation within the hippocampal CA1 area in rats under predictable and unpredictable chronic mild stress
Vajihe Saedi Marghmaleki, Maryam Radahmadi, Hojjatallah Alaei, et al.
Metabolic Brain Disease (2024)
Closed Access | Times Cited: 3
Elevated anxiety, hypoactivity, memory deficits, decreases of brain serotonin and 5-HT-1A receptors expression in rats treated with omeprazole
Sadia Basharat Ali, Khalid Mahmood, Raheel Saeed, et al.
Toxicological Research (2020) Vol. 37, Iss. 2, pp. 237-248
Open Access | Times Cited: 23
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update
Daniela Adamo, Elena Calabria, Noemi Coppola, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 18
New investigational agents for the treatment of major depressive disorder
Bartłomiej Pochwat, Anna Julia Krupa, Marcin Siwek, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 1053-1066
Closed Access | Times Cited: 13
Omeprazole affects the expression of serotonin-1A in the brain regions and alleviates anxiety in rat model of immobilization-induced stress
Sadia Basharat Ali, Raheel Saeed, Khalid Mahmood, et al.
Behavioural Pharmacology (2024) Vol. 35, Iss. 7, pp. 408-417
Closed Access | Times Cited: 2
Purple Sweet Potatoes from East Java of Indonesia Revealed the Macronutrient, Anthocyanin Compound and Antidepressant Activity Candidate
Nia Kurnianingsih, Retty Ratnawati, Tommy Alfandy Nazwar, et al.
Medical Archives (2021) Vol. 75, Iss. 2, pp. 94-94
Open Access | Times Cited: 15
Chronic exposure to metam sodium-based pesticide in mice during adulthood elevated anxiety and depression-like behaviors: Involvement of serotoninergic depletion and gut microbiota dysbiosis
Nour-eddine Kaikai, Saâdia Ba-M’hamed, Aiman Slimani, et al.
Environmental Toxicology and Pharmacology (2023) Vol. 98, pp. 104066-104066
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top